共 29 条
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition
被引:112
作者:
van de Wal, RMA
Plokker, HWM
Lok, DJA
Boomsma, F
van der Horst, FAL
van Veldhuisen, DJ
van Gilst, WH
Voors, AA
机构:
[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands
[2] Deventer Hosp, Dept Cardiol, NL-7515 CM Deventer, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
[4] St Antonius Hosp, Dept Clin Chem, NL-3435 CM Nieuwegein, Netherlands
[5] Univ Groningen Hosp, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[6] Univ Groningen, Dept Clin Pharmacol, NL-9713 AV Groningen, Netherlands
关键词:
angiotensin II;
chronic heart failure;
ACE inhibition;
D O I:
10.1016/j.ijcard.2005.02.016
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Introduction: The beneficial effects of ACE inhibitors are generally ascribed to blockade of neurohormonal activation. However, especially in chronic heart failure (CHF) patients plasina angiotensin II and aldosterone levels can be elevated despite ACE inhibition, the so-called ACE escape. In the present study, we aimed to identify the frequency and determinants of ACE escape in CHF patients. Methods: We studied 99 stable chronic heart failure patients (NYHA class III and IV, 66% ischemic etiology) receiving long-term therapy with ACE inhibitors. In all patients, cardiac, renal, and neurohormonal parameters were measured. ACE escape was defined as plasma angiotensin level >= 16 pmol/L. Results: Mean (SD) left ventricular ejection fraction of our 99 patients (79 men and 20 women,. age 69 +/- 12 years) was 28 +/- 10%. In addition to an ACE inhibitor, 93% of patients received diuretics, 71% a beta-blocker, and 49% spironolactone. None of the patients used an angiotensin receptor blocker. In our population, 45% of the patients had an angiotensin II plasma concentration higher than 16 pmol/L (median concentration was 14.1 pmol/L). Spironolactone use was an independent predictor of elevated plasma angiotensin II levels. Furthermore, spironolactone users had significantly higher plasma active renin protein and aldosterone levels. Plasma angiotensin It concentration was positively correlated to active renin, plasma angiotensin I and plasma aldosterone. No correlation was found between plasma angiotensin II levels and serum ACE activity, dose of ACE inhibitor, or duration of use. Conclusion: In a group of severe chronic heart failure patients, 45% had elevated plasma angiotensin II levels independent of serum ACE activity despite long-term ACE inhibitor use. Although a causal link could not be proven, an association was found between spironolactone use and active renin protein, angiotensin II and aldosterone levels, suggesting that escape from ACE is mainly caused by a feedback mechanism. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:367 / 372
页数:6
相关论文